Publisher
Heighten Science Publications Corporation
Reference68 articles.
1. Diarrhoeal disease through enterocyte secretion: a doctrine untroubled by proof;Lucas;Exp Physiol,2010
2. 2. Alton EWFW, Armstrong DK, Ashby D, Bayfield KJ, Bilton D, et al. A randomised, double blind, placebo-controlled trial of repeated nebulisation of non-viral cystic fibrosis transmembrane conductance regulator (CFTR) gene therapy in patients with cystic fibrosis. Efficiency and Mechanism Evaluation. 2016.
3. Amendments to the theory underlying Ussing chamber data of chloride ion secretion after bacterial enterotoxin exposure;Lucas;J Theor Biol,2005
4. A reconsideration of the evidence for Escherichia coli STa (heat stable) enterotoxin driven fluid secretion: a new view of STa action and a new paradigm for fluid absorption;Lucas;J Appl Microbiol,2001
5. 5. Lucas ML, Gilligan LC, Whitelaw CC, Wynne PJ, Morrison JD. Lack of restoration in vivo by K+-channel modulators of jejunal fluid absorption after heat stable Escherichia coli enterotoxin (STa) challenge J Trop Med. 2011; Article ID 853686: 7